- Our Doctors
- Dr Fred Azimi
Dr Fred Azimi
Bsc (Med) MBBS, MS (Surg Onc), FRACS, Surgical Oncologist
For patients/carers
For doctors
Bsc (Med) MBBS, MS (Surg Onc), FRACS, Surgical Oncologist
Locations
Clinical interests
- Breast cancer
- Skin cancer
- Non-melanoma skin cancer
- Head and neck cancer
Languages
Fluent
- English
- Farsi / فارسی
Biography
Dr Azimi is a Surgical Oncologist specialising in Skin, Breast, Head and neck, Endocrine cancers.
Dr Azimi is a Surgical Oncologist and General Surgeon. He has extensive sub-specialised training at major tertiary institutions which allow him to treat a broad range of conditions. These include benign and cancerous conditions of the skin, breast and head and neck. He also skilled at breast reconstruction surgery.
Dr. Azimi is chair of the skin MDT at Liverpool and a member of the head and neck unit at Liverpool hospital, head of general surgery at Liverpool hospital and co-chair of breast research at Chris O'Brien Lifehouse.
He is dedicated medical researcher who aims to contribute to medical innovation and to deliver the most up to date treatments to his patients.
More information
Dr Azimi's research interests are in melanoma and breast oncology.
- Head of General Surgery, Liverpool Hospital
- Fellow of the college of surgeons
- Breast Surg ANZ full member
- Lead breast research Chris O'Brien Lifehouse
- Australian and NZ endocrine surgeons
- Senior lecturer, UNSW
- Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. Journal of Clinical Oncology. 2012 Jul 20;30(21):2678-83
- Nguyen, Chu Luan & Easwaralingam, Neshanth & Seah, Jue Li & Azimi, Farhad & Mak, Cindy & Pulitano, Carlo & Warrier, Sanjay. (2024). Indocyanine green compared with technetium-99m for sentinel lymph node biopsy in breast cancer: the Flouro trial. The Breast. 74. 103664. 10.1016/j.breast.2023.103664.
- Hawes, S. & Graham, S. & Ang, S. & Azimi, Farhad & Mak, Cindy & Warrier, Sanjay. (2024). Targeted Dissection: A review of our experience at Chris O’Brien Life house. The Breast. 74. 103653. 10.1016/j.breast.2023.103653.
- Nguyen CL, Cui R, Zhou M, Ali F, Easwaralingam N, Chan B, Graham S, Azimi F, Mak C, Warrier S. Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local Excision of Non-palpable Breast Cancer. Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15142-x. Epub ahead of print. PMID: 38472677.
- Nguyen, Chu Luan & Dayaratna, Nirmal & Graham, Susannah & Azimi, Farhad & Mak, Cindy & Pulitano, Carlo & Warrier, Sanjay. (2024). Evolution of Indocyanine Green Fluorescence in Breast and Axilla Surgery: An Australasian Experience. Life, 14(1), 135.
- Harris, Christopher & Azimi, Farhad & Warrier, Sanjay & Eslick, Guy. (2023). Axillary dissection versus radiotherapy in sentinel node positive breast cancer: a meta-analysis of long-term recurrence and survival. 10.21203/rs.3.rs-3735209/v1.
You are leaving our website
You are now leaving our website. GenesisCare do not control this content and therefore are not responsible for its accuracy or reliability.
Explore more
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.